Featured this week:
- Brooks Jackson, MD, MBA
- Aaruni Khanolkar, MBBS, PhD
- The Human Papillomavirus Vaccine: Evidence for Safety, Efficacy, and Effectiveness. Voss N, Jackson JB, Rysavy MB. Vaccines March 2026; 14, 236. https://doi.org/10.3390/vaccines14030236
- Case Report: Novel MAGT1 pathogenic variant with significant atopy, hypogammaglobulinemia and viral skin infections. Front Immunol. 2026 Feb 16;17:1754394. doi: 10.3389/fimmu.2026.1754394. eCollection 2026. PMID: 41777878